Literature DB >> 24157592

Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy.

Tao Tian1, Yilu Wang, Kai Sun, Jizheng Wang, Yubao Zou, Weili Zhang, Jingru Bao, Ling Zhu, Hu Shen, Rutai Hui, Xianliang Zhou, Lei Song.   

Abstract

OBJECTIVES: The clinical outcomes of hypertrophic cardiomyopathy (HCM) are largely unpredictable. This study aimed to investigate the relationship between atrial fibrillation (AF) and its prognostic implications in Chinese patients with HCM.
METHODS: From 1999 to 2011, 654 unrelated HCM patients were consecutively recruited at Fuwai Hospital. Medical history, including electrocardiographic and echocardiographic data, was analyzed.
RESULTS: AF was documented in 158 patients (24%). During follow-up of 4.2 ± 2.8 years, Kaplan-Meier analysis revealed that the presence of AF was associated with an increased risk for all-cause death (p = 0.001), cardiovascular death (p < 0.001), severe heart failure (p < 0.001) and ischemic stroke (p < 0.001). Multivariate analysis identified AF as an independent predictor of stroke-related death (HR 6.71, 95% CI 1.23-38.58, p = 0.03), advanced heart failure (HR 1.83, 95% CI 1.04-3.22, p = 0.04) and ischemic stroke (HR 9.98, 95% CI 4.06-24.53, p < 0.001). Furthermore, enlarged left atrial diameter was positively related to all-cause death (HR 1.09, 95% CI 1.05-1.13, p < 0.001), cardiovascular death (HR 1.08, 95% CI 1.04-1.20, p < 0.001) and development of advanced heart failure (HR 1.05, 95% CI 1.01-1.10, p = 0.01).
CONCLUSIONS: AF predicts poor outcomes for patients with HCM. Left atrial dilation is also related to an adverse prognosis and provides additional prognostic information.

Entities:  

Mesh:

Year:  2013        PMID: 24157592     DOI: 10.1159/000354953

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  11 in total

Review 1.  [Medicinal treatment of atrial fibrillation in special situations].

Authors:  Dietrich Pfeiffer; Daniel Jurisch; Jens-Gerrit Kluge; Andreas Hagendorff; Norbert Klein
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-02-18

2.  Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review.

Authors:  Patricia Alphonse; Sohaib Virk; Jhonna Collins; Timothy Campbell; Stuart P Thomas; Christopher Semsarian; Saurabh Kumar
Journal:  Clin Res Cardiol       Date:  2020-09-03       Impact factor: 5.460

3.  Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy.

Authors:  C Fielder Camm; A John Camm
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

Review 4.  Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?

Authors:  Antonio Frontera; D G Wilson; H Sekhon; E R Duncan; G Thomas
Journal:  Clin Res Cardiol       Date:  2015-07-02       Impact factor: 5.460

5.  Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy.

Authors:  Mariusz Klopotowski; Aleksandra Kwapiszewska; Krzysztof Kukula; Jacek Jamiolkowski; Maciej Dabrowski; Pawel Derejko; Artur Oreziak; Rafal Baranowski; Mateusz Spiewak; Magdalena Marczak; Anna Klisiewicz; Barbara Szepietowska; Zbigniew Chmielak; Adam Witkowski
Journal:  Clin Cardiol       Date:  2018-10-16       Impact factor: 2.882

6.  Outcomes in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a survival meta-analysis.

Authors:  Ahmad Masri; Mohamed Kanj; Maran Thamilarasan; Oussama Wazni; Nicholas G Smedira; Harry M Lever; Milind Y Desai
Journal:  Cardiovasc Diagn Ther       Date:  2017-02

Review 7.  Hypertrophic Cardiomyopathy-Past, Present and Future.

Authors:  Alphonsus C Liew; Vassilios S Vassiliou; Robert Cooper; Claire E Raphael
Journal:  J Clin Med       Date:  2017-12-12       Impact factor: 4.241

8.  The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy.

Authors:  Xiying Guo; Chaomei Fan; Lei Tian; Yanling Liu; Hongyue Wang; Shihua Zhao; Fujian Duan; Xiuling Zhang; Xing Zhao; Fengqi Wang; Hongguang Zhu; Aiqing Lin; Xia Wu; Yishi Li
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

9.  Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.

Authors:  Jung-Chi Hsu; Ya-Ting Huang; Lian-Yu Lin
Journal:  Aging (Albany NY)       Date:  2020-11-23       Impact factor: 5.682

10.  Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model.

Authors:  Moumita Bhattacharya; Dai-Yin Lu; Ioannis Ventoulis; Gabriela V Greenland; Hulya Yalcin; Yufan Guan; Joseph E Marine; Jeffrey E Olgin; Stefan L Zimmerman; Theodore P Abraham; M Roselle Abraham; Hagit Shatkay
Journal:  CJC Open       Date:  2021-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.